ZA200606422B - Anthelmintic composition - Google Patents

Anthelmintic composition

Info

Publication number: ZA200606422B
Authority: ZA; South Africa
Prior art keywords: anthelmintic composition; anthelmintic; triclabendazole; milbemycin; laponite
Prior art date: 2004-02-03

Application number

ZA200606422A

Other languages

English (en)

Inventor

James S Rowe

Jon C Hayes

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-03

Filing date

2006-08-02

Publication date

2010-01-27

2006-08-02 Application filed by Wyeth Corp filed Critical Wyeth Corp

2010-01-27 Publication of ZA200606422B publication Critical patent/ZA200606422B/xx

Links

230000000507 anthelmentic effect Effects 0.000 title abstract 3
NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 abstract 1
239000005660 Abamectin Substances 0.000 abstract 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
229940094522 laponite Drugs 0.000 abstract 1
XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 abstract 1
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
239000006254 rheological additive Substances 0.000 abstract 1
229960000323 triclabendazole Drugs 0.000 abstract 1
229920001285 xanthan gum Polymers 0.000 abstract 1
229940082509 xanthan gum Drugs 0.000 abstract 1
235000010493 xanthan gum Nutrition 0.000 abstract 1
239000000230 xanthan gum Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Zoology (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Materials For Medical Uses (AREA)
Retarders (AREA)
Dry Shavers And Clippers (AREA)

ZA200606422A 2004-02-03 2006-08-02 Anthelmintic composition ZA200606422B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US54147204P	2004-02-03	2004-02-03

Publications (1)

Publication Number	Publication Date
ZA200606422B true ZA200606422B (en)	2010-01-27

Family

ID=34837494

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200606422A ZA200606422B (en)	2004-02-03	2006-08-02	Anthelmintic composition

Country Status (10)

Country	Link
US (1)	US20050245468A1 (fr)
AT (1)	ATE466578T1 (fr)
AU (1)	AU2005210632B2 (fr)
DE (1)	DE602005021054D1 (fr)
DK (1)	DK1713468T3 (fr)
ES (1)	ES2342668T3 (fr)
NZ (1)	NZ585223A (fr)
PT (1)	PT1713468E (fr)
WO (1)	WO2005074914A1 (fr)
ZA (1)	ZA200606422B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0520550B1 (pt) *	2005-09-15	2020-03-03	Merial, Inc	Fórmulas anti-helmínticas
KR20080073700A (ko) *	2005-12-06	2008-08-11	와이어쓰	벤즈이미다졸 비수성 조성물
ES2617672T3 (es) *	2008-10-08	2017-06-19	Zoetis Services Llc	Composiciones antihelmínticas de bencimidazol
BRPI0804639A2 (pt) *	2008-10-23	2010-07-20	Formil Veterinaria Ltda	processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água
GB0900473D0 (en) *	2009-01-13	2009-02-11	Univ Gent	Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
CN104523681B (zh) *	2014-12-17	2017-01-11	南京农业大学	一种驱虫缓释控释大丸剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4197307A (en) *	1977-04-12	1980-04-08	Ciba-Geigy Corporation	2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
EP0060810B1 (fr) *	1981-03-18	1984-10-17	Ciba-Geigy Ag	Anthelminthiques
NZ247278A (en) *	1991-02-12	1995-03-28	Ancare Distributors	Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
NZ335166A (en) *	1999-04-14	2001-11-30	Ashmont Holdings Ltd	Anthelmintic composition containing triclabendazole in at least one solvent
GB9205368D0 (en) *	1992-03-12	1992-04-22	Pfizer Ltd	Benzimidozole anthelmintic agents
AUPM969994A0 (en) *	1994-11-28	1994-12-22	Virbac S.A.	Equine anthelmintic formulations
AU707949C (en) *	1996-07-30	2006-01-19	Merial, Inc.	Anthelmintic formulations
EP1182931B1 (fr) *	1999-06-04	2005-12-28	Nufarm Limited	Compositions biocides stables
US6340672B1 (en) *	2000-02-16	2002-01-22	Phoenix Scientific, Inc.	Parasiticidal formulation and a method of making this formulation
ATE320812T1 (de) *	2000-10-10	2006-04-15	Wyeth Corp	Anthelmintika
CN1435176A (zh) *	2002-01-29	2003-08-13	王玉万	以表面活性剂为基础的含三氯苯哒唑的新制剂
AU2002952597A0 (en) *	2002-11-11	2002-11-28	Schering-Plough Pty. Limited	Topical parasiticide formulations and methods of treatment

2005
- 2005-02-01 AU AU2005210632A patent/AU2005210632B2/en not_active Ceased
- 2005-02-01 AT AT05706144T patent/ATE466578T1/de active
- 2005-02-01 ES ES05706144T patent/ES2342668T3/es not_active Expired - Lifetime
- 2005-02-01 NZ NZ585223A patent/NZ585223A/en unknown
- 2005-02-01 WO PCT/US2005/002794 patent/WO2005074914A1/fr not_active Ceased
- 2005-02-01 PT PT05706144T patent/PT1713468E/pt unknown
- 2005-02-01 DE DE602005021054T patent/DE602005021054D1/de not_active Expired - Lifetime
- 2005-02-01 US US11/047,923 patent/US20050245468A1/en not_active Abandoned
- 2005-02-01 DK DK05706144.2T patent/DK1713468T3/da active
2006
- 2006-08-02 ZA ZA200606422A patent/ZA200606422B/xx unknown

Also Published As

Publication number	Publication date
DK1713468T3 (da)	2010-08-16
AU2005210632A1 (en)	2005-08-18
ATE466578T1 (de)	2010-05-15
PT1713468E (pt)	2010-06-18
US20050245468A1 (en)	2005-11-03
WO2005074914A1 (fr)	2005-08-18
NZ585223A (en)	2011-01-28
AU2005210632B2 (en)	2011-02-03
ES2342668T3 (es)	2010-07-12
DE602005021054D1 (de)	2010-06-17

Publication	Publication Date	Title
WO2008005705A3 (fr)	2008-06-19	Formulations à teneur métallique et procédés d'utilisation
IL204732A (en)	2013-07-31	@@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs
NO20091509L (no)	2009-05-28	Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter
MY153921A (en)	2015-04-15	Aminopyrazole derivatives
MX2007015424A (es)	2008-04-17	Formulaciones ungueales topicas.
EP2012780A4 (fr)	2009-06-24	1h-benzimidazole-4-carboxamides substitués servant de puissants inhibiteurs de parp
WO2008017074A3 (fr)	2008-08-14	Teintures et précurseurs et leurs conjugués
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
PL1753440T3 (pl)	2008-05-30	Forma do podawania doustnego zawierająca bakterie probiotyczne
TW200738627A (en)	2007-10-16	Trialkylsilyl-indoles
SI1937669T1 (sl)	2012-05-31	Novi derivati benzopirana kot odpiralci kalijevega kanala
TW200740814A (en)	2007-11-01	Compounds
MX2009006337A (es)	2009-06-23	Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
MX2007000224A (es)	2007-06-15	Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
ECSP066822A (es)	2006-11-24	Macrólidos y métodos para producir los mismos
TW200700064A (en)	2007-01-01	Novel compounds
MX2008011576A (es)	2008-09-22	Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
ZA200606422B (en)	2010-01-27	Anthelmintic composition
UY28917A1 (es)	2005-12-30	Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
MX2007006042A (es)	2007-07-10	Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
WO2008098077A3 (fr)	2008-12-11	Composés thérapeutiques
WO2007027780A3 (fr)	2007-07-12	Nouveaux derives de benzopyrane en tant qu'agents d'ouverture de canal potassique
ZA200903193B (en)	2010-03-31	Novel Morphine derivatives
WO2009124723A9 (fr)	2010-03-18	Nouveaux dérivés d'auréothine
WO2006078833A3 (fr)	2006-11-16	Utilisation de nouveaux derives de la coumarine comme agents d'ouverture de canaux ioniques